Navigation Links
NW Bio's Dr. Marnix Bosch To Present At Brain Tumor Biotech Summit In New York
Date:6/6/2013

BETHESDA, Md., June 6, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, today announced that its Chief Technical Officer, Dr. Marnix Bosch , will make a presentation at the Brain Tumor Biotech Summit sponsored by the Weill Cornell Medical College and Voices Against Brain Cancer in New York City, New York on Friday, June 7, 2013.   

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

Dr. Bosch will review NW Bio's non-toxic personalized immune therapies for both operable and inoperable brain tumors, and the clinical trial programs for each of these.

This will include the ongoing 312-patient Phase III international trial of DCVax-L for Glioblastoma multiforme brain cancer, which is currently enrolling patients in both the US and Europe. 

It will also include review of the Phase I/II trial of DCVax-Direct, which is expected to be launching soon for all inoperable solid tumors, including tumors that have metastasized to the brain from other locations.   

Dr. Bosch will be presenting at the Weill Cornell Medical College's Uris Auditorium at 8:20 am on Friday, June 7, 2013. The Auditorium is located at 1300 New York Avenue at 69th Street. Dr. Bosch's presentation will be available on the NW Bio Website starting at 10:00 am on Friday morning June 7, 2013.

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind asso
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion
2. Cynvenio Biosystems to Present Clinical Data on Mutational Analysis of LiquidBiopsy® Tumor Samples at the 2013 ASCO Annual Meeting
3. BioScrip To Present At Jefferies 2013 Global Healthcare Conference
4. PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756
5. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
6. Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013
7. Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference
8. Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
9. Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
10. Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference
11. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... October 21, 2014 The North American ... market North America with analysis and forecast of revenue. ... and is expected to reach $623.6 million by 2018, ... , Browse through the TOC of the North American ... the in-depth analysis provided. This also provides a glimpse ...
(Date:10/22/2014)... 2014 Currently offering a comprehensive ... D Weighing, Rice Lake, and Ohaus, Pipette.com has ... The Sartorius CPA Semi-Micro Balance is ideal for ... and user-friendly laboratory balance. , Sartorius is a ... laboratory balances are well known for their high ...
(Date:10/22/2014)... 22, 2014   Synthetic Biologics, Inc. (NYSE ... for serious infections and diseases, announced today that the ... of Allowance for a composition of matter patent application ... program, SYN-004. This is Synthetic Biologics, first allowed ... and adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... and HONG KONG , ... rare disease therapeutics enterprise, announced today that rare disease ... company as vice president, research. Dr. McKew brings more ... key leadership positions at the National Institutes of Health, ... acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts to ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... new study by a team including scientists from the National ... films can have different properties depending on the method by ... is necessary to explore the best way of creating these ... to computer memory devices. Thin films spread atop a ...
... 3, 2012 PDL BioPharma, Inc. (PDL) (NASDAQ: ... ended March 31, 2012. (Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ) ... increased five percent over the same period of 2011. Total ... compared to $83.3 million for the same period of 2011. ...
... VRNM ), a leading industrial biotechnology company focused on ... announced that it will release 2012 first quarter financial results ... with the release, the Company will host a conference call ... ET. The call may be accessed by dialing ...
Cached Biology Technology:Fabrication method can affect the use of block copolymer thin films 2PDL BioPharma Announces First Quarter 2012 Financial Results 2PDL BioPharma Announces First Quarter 2012 Financial Results 3PDL BioPharma Announces First Quarter 2012 Financial Results 4PDL BioPharma Announces First Quarter 2012 Financial Results 5Verenium Corporation To Announce First Quarter 2012 Financial Results 2
(Date:10/25/2014)... , Oct. 22, 2014 A recent ... analysis of the current and future genetic testing market. ... and types are covered in this report. On account ... trends; drivers; and existing strengths and challenges; forecast for ... market is likely to grow at a CAGR of ...
(Date:10/22/2014)... Oct. 20, 2014  Leading identity analyst firm Acuity ... of the world,s population will have a chip-based National ... Europe . Asia , with ... accounting for more than 60% of all National eID ... report  -- "The Global National eID Industry ...
(Date:10/18/2014)... a group of 2,000 patients referred for evaluation ... potential molecular diagnosis for 25 percent, including detection ... new mutations contributing to disease, according to a ... is being released to coincide with the American ... sequencing analyzes the exons or coding regions of ...
Breaking Biology News(10 mins):Genetic Testing Market Outlook 2018 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Whole-exome sequencing shows potential as diagnostic tool 2
... 2 October 2009] A derivative of cholesterol is necessary ... study from the Swedish medical university Karolinska Institutet. The ... Stem Cell , can help scientists to cultivate dopamine-producing ... led by Professor Ernest Arenas and demonstrates that the ...
... Center for Molecular Medicine (MDC) Berlin-Buch has been honored ... National Academy of Sciences Leopoldina and the Stifterverband fr ... GDR civil rights activist received the award for his ... The award was presented to him at the annual ...
... may be a source of green, renewable hydrocarbons that ... according to a team of researchers led by Iowa ... R. Hoppe Professor of Chemical Engineering, said some plants ... carbon and energy. And those hydrocarbons could be used ...
Cached Biology News:Professor Jens Reich first recipient of the Carl Friedrich von Weizsacker award 2Professor Jens Reich first recipient of the Carl Friedrich von Weizsacker award 3Iowa State researchers looking for catalyst that allows plants to produce hydrocarbons 2
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... expertise that made the original Gene Pulser apparatus ... available has been applied in the Gene Pulser ... modular design of the Gene Pulser II system ... that has the widest range of settings to ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
Biology Products: